ArticleClinical and experimental medicine2023

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.

Olga Sokolowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.